HYPERFERRITINAEMIA

This adverse event was reported 431 times

These drugs are most commonly taken by patients reporting HYPERFERRITINAEMIA:

# Drug Count
0 PREDNISONE 52
1 CYCLOPHOSPHAMIDE 50
2 CYCLOPHOSPHAMIDE FOR INJECTION 50
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 50
4 ANAKINRA 46
5 DEXAMETHASONE 41
6 DEXAMETHASONE 1.5 MG 41
7 METHOTREXATE SODIUM 39
8 TOCILIZUMAB 39
9 TACROLIMUS 36
See all common drugs associated with HYPERFERRITINAEMIA

HYPERFERRITINAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TELMISARTAN AND AMLODIPINE 3 0.0300
1 AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE 1 0.0200
2 EMAPALUMAB-LZSG 3 0.0127
3 TOCILIZUMAB-AAZG 3 0.0049
4 VADADUSTAT 1 0.0033
5 SILTUXIMAB 2 0.0031
6 ANAKINRA 46 0.0027
7 DELANDISTROGENE MOXEPARVOVEC-ROKL 1 0.0027
8 TREOSULFAN 7 0.0025
9 CANAKINUMAB 24 0.0022
See all drugs enriched for association with HYPERFERRITINAEMIA